Literature DB >> 3317855

Mechanisms of infection in chronic lymphocytic leukemia.

H M Chapel1, C Bunch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3317855

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  11 in total

1.  Correction of neutropenia associated with chronic lymphocytic leukaemia following treatment with granulocyte-macrophage colony-stimulating factor.

Authors:  A A Hollander; H C Kluin-Nelemans; H R Haak; A C Stern; R Willemze; W E Fibbe
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

Review 2.  Immune deficiencies in chronic lymphocytic leukemia and multiple myeloma.

Authors:  A Winkelstein; P S Jordan
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

Review 3.  Intravenous immunoglobulin for secondary immunodeficiency.

Authors:  P L Yap
Journal:  Blut       Date:  1990-01

4.  Intravenous immune globulin in chronic lymphocytic leukaemia.

Authors:  H Gamm; C Huber; H Chapel; M Lee; F Ries; M A Dicato
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

5.  Survey of infection in patients receiving antibody replacement treatment for immune deficiency.

Authors:  S J Pettit; H Bourne; G P Spickett
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

Review 6.  Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions.

Authors:  Helen Chapel; Charlotte Cunningham-Rundles
Journal:  Br J Haematol       Date:  2009-03-30       Impact factor: 6.998

7.  Predictors of infection in chronic lymphocytic leukaemia (CLL).

Authors:  H Griffiths; J Lea; C Bunch; M Lee; H Chapel
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

Review 8.  Immunological and genetic abnormalities in chronic lymphocytic leukaemia. Impact of the purine analogues.

Authors:  G Juliusson
Journal:  Drugs       Date:  1994       Impact factor: 9.546

Review 9.  Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy.

Authors:  Silvia Sánchez-Ramón; Fatima Dhalla; Helen Chapel
Journal:  Front Immunol       Date:  2016-08-22       Impact factor: 7.561

10.  Infectious complications in chronic lymphocytic leukemia.

Authors:  Annamaria Nosari
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-11-05       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.